VWF and Hepatic fibrosis: Although we found that sorafenib alone significantly inhibited the increases in vWF, CD31, VEGF, Ang1 and VACM1 expression observed in DMN-induced liver fibrosis, sorafenib could not decrease significantly Col1 (α1) expression or Hyp content.